06/12/2023  TG Branfalt

Five years after the United Kingdom’s Home Office legalized medical cannabis products for use on the National Health Service (NHS), the government still hasn’t funded clinical trials that would allow physicians to prescribe cannabis, Sky News reports. Patients with private insurance can access medical cannabis products, but those who rely on NHS cannot.  

Dr. Alan Fayaz, an NHS consultant and a spokesperson for the British Pain Society, told Sky News that the 2018 decision by the Home Office to legalize medical cannabis before clinical trials has created “this bizarre two-tiered system which actually doesn’t advantage the patients on the NHS” and “doesn’t really advantage the patients in the private sector either.” 


Read More